TGFBR2 and breast carcinoma: During cancer progression, growth factor-induced (or oncogenic mutation) activation of AKT mediates FAF1 phosphorylation and its dissociation from the plasma membrane and TβRII, thereby reinforcing TβRII stability on the cell surface and activating the pro-metastatic functions induced by TGF-β in breast cancer cells.